Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Effect of Polymer Phase Transition Behavior on Temperature-Responsive Polymer-Modified Liposomes for siRNA Transfection.

Nagase K, Hasegawa M, Ayano E, Maitani Y, Kanazawa H.

Int J Mol Sci. 2019 Jan 19;20(2). pii: E430. doi: 10.3390/ijms20020430.

2.

Liposomes with temperature-responsive reversible surface properties.

Nemoto R, Fujieda K, Hiruta Y, Hishida M, Ayano E, Maitani Y, Nagase K, Kanazawa H.

Colloids Surf B Biointerfaces. 2019 Apr 1;176:309-316. doi: 10.1016/j.colsurfb.2019.01.007. Epub 2019 Jan 3.

PMID:
30641302
3.

Adaptive frequency shifts of echolocation sounds in Miniopterus fuliginosus according to the frequency-modulated pattern of jamming sounds.

Maitani Y, Hase K, Kobayasi KI, Hiryu S.

J Exp Biol. 2018 Oct 15. pii: jeb.188565. doi: 10.1242/jeb.188565. [Epub ahead of print]

PMID:
30322982
4.

Bats enhance their call identities to solve the cocktail party problem.

Hase K, Kadoya Y, Maitani Y, Miyamoto T, Kobayasi KI, Hiryu S.

Commun Biol. 2018 May 3;1:39. doi: 10.1038/s42003-018-0045-3. eCollection 2018.

5.

Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.

Wang J, Ayano E, Maitani Y, Kanazawa H.

Int J Pharm. 2017 May 15;523(1):217-228. doi: 10.1016/j.ijpharm.2017.03.035. Epub 2017 Mar 19.

PMID:
28330734
6.

Tunable Surface Properties of Temperature-Responsive Polymer-Modified Liposomes Induce Faster Cellular Uptake.

Wang J, Ayano E, Maitani Y, Kanazawa H.

ACS Omega. 2017 Jan 31;2(1):316-325. doi: 10.1021/acsomega.6b00342. eCollection 2017 Jan 31.

7.

Exploring the relationship between anti-PEG IgM behaviors and PEGylated nanoparticles and its significance for accelerated blood clearance.

Shiraishi K, Kawano K, Maitani Y, Aoshi T, Ishii KJ, Sanada Y, Mochizuki S, Sakurai K, Yokoyama M.

J Control Release. 2016 Jul 28;234:59-67. doi: 10.1016/j.jconrel.2016.05.010. Epub 2016 May 6.

PMID:
27164541
8.

Determination of polymeric micelles' structural characteristics, and effect of the characteristics on pharmacokinetic behaviors.

Shiraishi K, Sanada Y, Mochizuki S, Kawano K, Maitani Y, Sakurai K, Yokoyama M.

J Control Release. 2015 Apr 10;203:77-84. doi: 10.1016/j.jconrel.2015.02.017. Epub 2015 Feb 14.

PMID:
25687307
9.

siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.

Hattori Y, Nakamura A, Arai S, Kawano K, Maitani Y, Yonemochi E.

J Liposome Res. 2015;25(4):279-86. doi: 10.3109/08982104.2014.992024. Epub 2015 Sep 4.

PMID:
25543847
10.

Development of liposomal nanoconstructs targeting P-selectin (CD62P)-expressing cells by using a sulfated derivative of sialic acid.

Itoh S, Kawano K, Takeshita K, Maitani Y, Tsuji T.

Pharm Res. 2014 Oct;31(10):2868-75. doi: 10.1007/s11095-014-1383-6. Epub 2014 May 3.

PMID:
24792831
11.
12.

In vivo siRNA delivery system for targeting to the liver by poly-l-glutamic acid-coated lipoplex.

Hattori Y, Nakamura A, Arai S, Nishigaki M, Ohkura H, Kawano K, Maitani Y, Yonemochi E.

Results Pharma Sci. 2014 Jan 25;4:1-7. doi: 10.1016/j.rinphs.2014.01.001. eCollection 2014.

13.

Topical application of polyethylenimine as a candidate for novel prophylactic therapeutics against genital herpes caused by herpes simplex virus.

Hayashi K, Onoue H, Sasaki K, Lee JB, Kumar PK, Gopinath SC, Maitani Y, Kai T, Hayashi T.

Arch Virol. 2014 Mar;159(3):425-35. doi: 10.1007/s00705-013-1829-x. Epub 2013 Sep 18.

PMID:
24046087
14.

Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma.

Kawano K, Hattori Y, Iwakura H, Akamizu T, Maitani Y.

Cancer Med. 2013 Jun;2(3):286-95. doi: 10.1002/cam4.76. Epub 2013 Apr 2.

15.

Enhanced plasmid DNA transfer into tumor cells by nanoparticle composed of cholesteryl triamine and diamine.

Hattori Y, Nakamura T, Ohno H, Fujii N, Maitani Y.

Biol Pharm Bull. 2013;36(5):856-60.

16.

Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection.

Hattori Y, Yamasaku H, Maitani Y.

J Drug Target. 2013 Aug;21(7):639-47. doi: 10.3109/1061186X.2013.789035. Epub 2013 Apr 17.

PMID:
23594095
17.

Accuracy of equilibrium magnetization mapping in sliced two-dimensional spoiled gradient-recalled echo pulse sequence with variable flip angle.

Kuribayashi H, Sekino M, Minowa T, Maitani Y, Ohsaki H, Tsushima S, Hirai S, Ueda M, Katayama Y.

J Magn Reson Imaging. 2013 Nov;38(5):1245-50. doi: 10.1002/jmri.24023. Epub 2013 Feb 6.

PMID:
23390025
18.

Higher lung accumulation of intravenously injected organic nanotubes.

Maitani Y, Nakamura Y, Kon M, Sanada E, Sumiyoshi K, Fujine N, Asakawa M, Kogiso M, Shimizu T.

Int J Nanomedicine. 2013;8:315-23. doi: 10.2147/IJN.S38462. Epub 2013 Jan 18.

19.

Polyethylenimine combined with liposomes and with decreased numbers of primary amine residues strongly enhanced therapeutic antiviral efficiency against herpes simplex virus type 2 in a mouse model.

Maitani Y, Ishigaki K, Nakazawa Y, Aragane D, Akimoto T, Iwamizu M, Kai T, Hayashi K.

J Control Release. 2013 Mar 10;166(2):139-46. doi: 10.1016/j.jconrel.2012.12.027. Epub 2013 Jan 5.

PMID:
23298614
20.

siRNA delivery into tumor cells by lipid-based nanoparticles composed of hydroxyethylated cholesteryl triamine.

Hattori Y, Nakamura T, Ohno H, Fujii N, Maitani Y.

Int J Pharm. 2013 Feb 25;443(1-2):221-9. doi: 10.1016/j.ijpharm.2012.12.017. Epub 2012 Dec 30.

PMID:
23279939
21.

Transdermal Delivery of Small Interfering RNA with Elastic Cationic Liposomes in Mice.

Hattori Y, Date M, Arai S, Kawano K, Yonemochi E, Maitani Y.

J Pharm (Cairo). 2013;2013:149695. doi: 10.1155/2013/149695. Epub 2013 Dec 26.

22.

Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon.

Shiraishi K, Hamano M, Ma H, Kawano K, Maitani Y, Aoshi T, Ishii KJ, Yokoyama M.

J Control Release. 2013 Feb 10;165(3):183-90. doi: 10.1016/j.jconrel.2012.11.016. Epub 2012 Dec 3.

PMID:
23220106
23.

Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers.

Koganei H, Ueno M, Tachikawa S, Tasaki L, Ban HS, Suzuki M, Shiraishi K, Kawano K, Yokoyama M, Maitani Y, Ono K, Nakamura H.

Bioconjug Chem. 2013 Jan 16;24(1):124-32. doi: 10.1021/bc300527n. Epub 2012 Dec 19.

PMID:
23214414
25.

Involvement of transcription factor Ets-1 in the expression of the α3 integrin subunit gene.

Kamoshida G, Matsuda A, Katabami K, Kato T, Mizuno H, Sekine W, Oku T, Itoh S, Tsuiji M, Hattori Y, Maitani Y, Tsuji T.

FEBS J. 2012 Dec;279(24):4535-46. doi: 10.1111/febs.12040. Epub 2012 Nov 22.

26.

Adrenal tumor volume in a genetically engineered mouse model of neuroblastoma determined by magnetic resonance imaging.

Kawano K, Hattori Y, Iwakura H, Akamizu T, Maitani Y.

Exp Ther Med. 2012 Jul;4(1):61-64. Epub 2012 May 2.

27.

A combination of liposomal sunitinib plus liposomal irinotecan and liposome co-loaded with two drugs enhanced antitumor activity in PC12-bearing mouse.

Maitani Y, Saito H, Seishi Y, Iwase Y, Yamauchi T, Higashiyama K, Sugino T.

J Drug Target. 2012 Dec;20(10):873-82. doi: 10.3109/1061186X.2012.723215. Epub 2012 Oct 11.

PMID:
23050928
28.

Menthosomes, novel ultradeformable vesicles for transdermal drug delivery: optimization and characterization.

Duangjit S, Obata Y, Sano H, Kikuchi S, Onuki Y, Opanasopit P, Ngawhirunpat T, Maitani Y, Takayama K.

Biol Pharm Bull. 2012;35(10):1720-8.

29.

Functional coating of liposomes using a folate- polymer conjugate to target folate receptors.

Watanabe K, Kaneko M, Maitani Y.

Int J Nanomedicine. 2012;7:3679-88. doi: 10.2147/IJN.S32853. Epub 2012 Jul 13.

30.
32.

Early entry and deformation of macropinosomes correlates with high efficiency of decaarginine-polyethylene glycol-lipid-mediated gene delivery.

Kobayashi S, Hattori Y, Osakada H, Toma K, Maitani Y, Hiraoka Y, Haraguchi T.

J Gene Med. 2012 Apr;14(4):262-71. doi: 10.1002/jgm.2615.

PMID:
22351041
33.

Hydration of surfactant-modified and PEGylated cationic cholesterol-based liposomes and corresponding lipoplexes by monitoring a fluorescent probe and the dielectric relaxation time.

Maitani Y, Nakamura A, Tanaka T, Aso Y.

Int J Pharm. 2012 May 10;427(2):372-8. doi: 10.1016/j.ijpharm.2012.02.018. Epub 2012 Feb 18.

PMID:
22348874
35.

Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex.

Kato M, Hattori Y, Kubo M, Maitani Y.

Int J Pharm. 2012 Feb 28;423(2):428-34. doi: 10.1016/j.ijpharm.2011.12.015. Epub 2011 Dec 17.

PMID:
22197775
36.

Antitumor effect of liposomal histone deacetylase inhibitor-lipid conjugates in vitro.

Hattori Y, Nagaoka Y, Kubo M, Yamasaku H, Ishii Y, Okita H, Nakano H, Uesato S, Maitani Y.

Chem Pharm Bull (Tokyo). 2011;59(11):1386-92.

37.

Dual functional octreotide-modified liposomal irinotecan leads to high therapeutic efficacy for medullary thyroid carcinoma xenografts.

Iwase Y, Maitani Y.

Cancer Sci. 2012 Feb;103(2):310-6. doi: 10.1111/j.1349-7006.2011.02128.x. Epub 2011 Nov 22.

38.

Tumor environment changed by combretastatin derivative (Cderiv) pretreatment that leads to effective tumor targeting, MRI studies, and antitumor activity of polymeric micelle carrier systems.

Shiraishi K, Harada Y, Kawano K, Maitani Y, Hori K, Yanagihara K, Takigahira M, Yokoyama M.

Pharm Res. 2012 Jan;29(1):178-86. doi: 10.1007/s11095-011-0525-3. Epub 2011 Jul 26.

PMID:
21789726
39.

Effectiveness assessment of vaccination policy against measles epidemic in Japan using an age-time two-dimensional mathematical model.

Maitani Y, Ishikawa H.

Environ Health Prev Med. 2012 Jan;17(1):34-43. doi: 10.1007/s12199-011-0217-y. Epub 2011 May 7.

40.

Organic nanotubes for drug loading and cellular delivery.

Wakasugi A, Asakawa M, Kogiso M, Shimizu T, Sato M, Maitani Y.

Int J Pharm. 2011 Jul 15;413(1-2):271-8. doi: 10.1016/j.ijpharm.2011.04.038. Epub 2011 Apr 21.

PMID:
21540092
41.

Effects of polyethylene glycol spacer length and ligand density on folate receptor targeting of liposomal Doxorubicin in vitro.

Kawano K, Maitani Y.

J Drug Deliv. 2011;2011:160967. doi: 10.1155/2011/160967. Epub 2010 Dec 15.

42.

Octreotide-targeted liposomes loaded with CPT-11 enhanced cytotoxicity for the treatment of medullary thyroid carcinoma.

Iwase Y, Maitani Y.

Mol Pharm. 2011 Apr 4;8(2):330-7. doi: 10.1021/mp100380y. Epub 2011 Jan 18.

PMID:
21166471
43.

[Tumor permeability of nanocarriers observed by dynamic contrast-enhanced magnetic resonance imaging].

Kawano K, Maitani Y.

Yakugaku Zasshi. 2010 Dec;130(12):1679-85. Review. Japanese.

44.

Cell line-dependent internalization pathways determine DNA transfection efficiency of decaarginine-PEG-lipid.

Izumisawa T, Hattori Y, Date M, Toma K, Maitani Y.

Int J Pharm. 2011 Feb 14;404(1-2):264-70. doi: 10.1016/j.ijpharm.2010.11.017. Epub 2010 Nov 18.

PMID:
21093557
45.

Effects of organic solvents on drug incorporation into polymeric carriers and morphological analyses of drug-incorporated polymeric micelles.

Harada Y, Yamamoto T, Sakai M, Saiki T, Kawano K, Maitani Y, Yokoyama M.

Int J Pharm. 2011 Feb 14;404(1-2):271-80. doi: 10.1016/j.ijpharm.2010.11.016. Epub 2010 Nov 18.

PMID:
21093556
46.

Angiotensin II-induced hypertension enhanced therapeutic efficacy of liposomal doxorubicin in tumor-bearing mice.

Hattori Y, Ubukata H, Kawano K, Maitani Y.

Int J Pharm. 2011 Jan 17;403(1-2):178-84. doi: 10.1016/j.ijpharm.2010.10.009. Epub 2010 Oct 8.

PMID:
20934498
47.

Development of an in vitro drug release assay of PEGylated liposome using bovine serum albumin and high temperature.

Hioki A, Wakasugi A, Kawano K, Hattori Y, Maitani Y.

Biol Pharm Bull. 2010;33(9):1466-70.

48.

Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics.

Shiraishi K, Kawano K, Maitani Y, Yokoyama M.

J Control Release. 2010 Dec 1;148(2):160-7. doi: 10.1016/j.jconrel.2010.08.018. Epub 2010 Sep 6.

PMID:
20804796
49.

Combination of RET siRNA and irinotecan inhibited the growth of medullary thyroid carcinoma TT cells and xenografts via apoptosis.

Koga K, Hattori Y, Komori M, Narishima R, Yamasaki M, Hakoshima M, Fukui T, Maitani Y.

Cancer Sci. 2010 Apr;101(4):941-7. doi: 10.1111/j.1349-7006.2009.01484.x.

50.

Molecular characterization of tumors from a transgenic mouse adrenal tumor model: comparison with human pheochromocytoma.

Hattori Y, Kanamoto N, Kawano K, Iwakura H, Sone M, Miura M, Yasoda A, Tamura N, Arai H, Akamizu T, Nakao K, Maitani Y.

Int J Oncol. 2010 Sep;37(3):695-705.

PMID:
20664939

Supplemental Content

Loading ...
Support Center